J MED VIROL
| WoS 期刊 JCR 分区 (2026 · JIF) | 综合 SCIE | Q1 | ||
|---|---|---|---|---|
| 学科 | 收录集 | JIF 分区 | JIF 排名 | JIF 百分位 |
| 病毒学 Virology | SCIE | Q2 | 16/44 |
63.6%
|
| 学科 | 收录集 | JCI 分区 | JCI 排名 | JCI 百分位 |
|---|---|---|---|---|
| 病毒学 Virology | SCIE | Q1 | 4/35 JCI 1.67 |
91.4%
|
The Journal of Medical Virology (J MED VIROL, ISSN 0146-6615) is a well-established peer-reviewed periodical dedicated to the rapid publication of original research and critical reviews on all aspects of human and animal virology. Its scope encompasses the epidemiology, pathogenesis, diagnosis, prevention, and treatment of viral infections, with a strong emphasis on translational and clinical applications. The journal covers a broad spectrum of topics, including viral immunology, antiviral therapy, vaccine development, emerging viral diseases, and the molecular biology of viruses such as HIV, hepatitis viruses, influenza, coronaviruses, and herpesviruses. The primary article types published include original research articles, comprehensive reviews, short communications, and case reports, all subjected to rigorous peer review. The target audience is diverse, comprising virologists, infectious disease specialists, epidemiologists, public health researchers, and clinical laboratory scientists. Published by Wiley, the journal offers both subscription and open access options, allowing authors to choose open access publication for broader dissemination. With a 2026 Impact Factor of 3.7000, the Journal of Medical Virology holds a respected position in the field, consistently ranking in JCR Quartile 2 (Q2) within the virology category. This standing reflects its consistent contribution to timely, high-quality research that bridges laboratory findings and clinical practice, making it a valuable resource for professionals seeking current insights into viral pathogenesis and patient management.